Nordicus Partners Corporation (OTCPK: NORD)
Health Care · Biotechnology · US
$4.08
+1.77% today · -19.2% 1Y
Nordicus Partners Corporation (OTCPK: NORD) operates in the Biotechnology industry within the Health Care sector. The company is valued at $79.33M and employs 15 people.
Over the last twelve months the share price has lost 19.2%, trading between 1.48 and 5.95.
Tweenvest scores Nordicus Partners Corporation across four factors: quality 25/100, value 49/100. Its strongest factor is value.
NORD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $79.33M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.27
- Dividend yield
- —
- Beta (5Y)
- -0.48
- 52-week high
- $5.95
- 52-week low
- $1.48
- Avg volume (3M)
- —
- Shares outstanding
- 19.44M
- Employees
- 15
- Next earnings
- —
About Nordicus Partners Corporation
Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
- ISIN
- US28265K3041
- Founded
- 1993
- Listed since
- Jun 12, 1996
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sera Prognostics, Inc.NasdaqGM: SERA | $80.48M | $2.06 | +0.74% |
| Greenland Mines LtdNasdaqCM: GRML | $80.35M | $5.46 | -9.39% |
| GlycoNex IncorporationTPEX: 4168 | $80.23M | NT$22.80 | +1.79% |
| BioPorto A/SCPSE: BIOPOR | $79.36M | Dkr1.04 | -2.80% |
| Brii Biosciences LimitedSEHK: 2137 | $79.11M | HK$0.86 | -3.37% |
| Pelthos Therapeutics Inc.NYSEAM: PTHS | $78.48M | $20.29 | -1.02% |
| Cell Biotech Co., Ltd.KOSDAQ: A049960 | $78.19M | ₩15,360.00 | -1.54% |
| CORESTEMCHEMON Inc.KOSDAQ: A166480 | $77.21M | ₩2,340.00 | +1.08% |
Figures last refreshed Oct 11, 2026.